{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T03:32:22Z","timestamp":1648611142175},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"Supplement_5","license":[{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>With a newly World Health Organization (WHO)\u2013prequalified typhoid conjugate vaccine (TCV), Gavi funding for eligible countries, and a WHO policy recommendation for TCV use, now is the time for countries to introduce TCVs as part of an integrated typhoid control program, particularly in light of the increasing burden of antimicrobial resistance. Continued vaccine development efforts will lead to secure supply of low-cost vaccines, and ongoing vaccine studies will provide critical vaccine performance data and inform optimal deployment strategies, in both routine use and in outbreak settings. TCV programs should include thoughtful communication planning and community engagement to counter vaccine hesitancy.<\/jats:p>","DOI":"10.1093\/cid\/ciz483","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T11:10:55Z","timestamp":1559819455000},"page":"S408-S411","source":"Crossref","is-referenced-by-count":3,"title":["Toward Control? The Prospects and Challenges of Typhoid Conjugate Vaccine Introduction"],"prefix":"10.1093","volume":"69","author":[{"given":"Megan E","family":"Carey","sequence":"first","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoey I","family":"Diaz","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Broadstock","sequence":"additional","affiliation":[{"name":"Immunology and Vaccines, Medical Research Council, London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roderick","family":"Bailey","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Ethics and Humanities, University of Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adwoa D","family":"Bentsi-Enchill","sequence":"additional","affiliation":[{"name":"Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi J","family":"Larson","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, United Kingdom"},{"name":"Department of Health Metrics and Evaluation, University of Washington, Seattle"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,10,15]]},"reference":[{"key":"2019103013473843200_CIT0001","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive Salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2019103013473843200_CIT0002","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1093\/infdis\/jiy522","article-title":"Phase I of the surveillance for enteric fever in Asia project (SEAP): an overview and lessons learned","volume":"218","author":"Barkume","year":"2018","journal-title":"J Infect Dis"},{"key":"2019103013473843200_CIT0003","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016283","article-title":"on behalf of the STRATAA Study Consortium, et al. The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys","volume":"7:","author":"Darton","year":"2017","journal-title":"BMJ Open"},{"key":"2019103013473843200_CIT0004","first-page":"729","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization, October 2017\u2014conclusions and recommendations","volume":"48","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"2019103013473843200_CIT0005","unstructured":"World Health Organization. Typhoid vaccine prequalified. Available at: http:\/\/www.who.int\/medicines\/news\/2017\/WHOprequalifies-breakthrough-typhoid-vaccine\/en\/. Accessed May 2018."},{"key":"2019103013473843200_CIT0006","author":"Gavi, the Vaccine Alliance"},{"key":"2019103013473843200_CIT0007","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1016\/j.vaccine.2017.08.001","article-title":"The Typhoid Vaccine Acceleration Consortium (TyVAC): vaccine effectiveness study designs: accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26-27 October 2016, Oxford, UK","volume":"35","author":"Meiring","year":"2017","journal-title":"Vaccine"},{"key":"2019103013473843200_CIT0008","first-page":"153","article-title":"Typhoid vaccines: WHO position paper\u2014March 2018","volume":"13","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"2019103013473843200_CIT0009","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.1093\/cid\/ciz610","article-title":"Water and Filth","volume":"69","author":"Vanderslott","year":"2019","journal-title":"Clin Inf Dis"},{"key":"2019103013473843200_CIT0010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/infdis\/jiy324","article-title":"Urban slums: a supportive ecosystem for typhoidal salmonellae","volume":"218","author":"Luby","year":"2018","journal-title":"J Infect Dis"},{"key":"2019103013473843200_CIT0011","doi-asserted-by":"crossref","first-page":"S395","DOI":"10.1093\/cid\/ciz611","article-title":"The invisible burden","volume":"69","author":"Pitzer","year":"2019","journal-title":"Clin Inf Dis"},{"key":"2019103013473843200_CIT0012","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1093\/cid\/ciz551","article-title":"Biohistorical Perspective of Typhoid and Antimicrobial Resistance","volume":"69","author":"Kirchhelle","year":"2019","journal-title":"Clin Inf Dis"},{"key":"2019103013473843200_CIT0013","doi-asserted-by":"crossref","first-page":"e00482","DOI":"10.1128\/mBio.00482-18","article-title":"The gathering storm: is untreatable typhoid fever on the way?","volume":"9","author":"Levine","year":"2018","journal-title":"mBio"},{"key":"2019103013473843200_CIT0014","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/cid\/civ976","article-title":"Challenges and opportunities for typhoid fever control: a call for coordinated action","volume":"62","author":"Steele","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2019103013473843200_CIT0015","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1093\/cid\/ciy928","article-title":"A global agenda for typhoid control\u2014a perspective from the Bill & Melinda Gates Foundation","volume":"68","author":"Carey","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2019103013473843200_CIT0016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/cid\/ciy884","article-title":"Overview of the typhoid conjugate vaccine pipeline: current status and future plans","volume":"68","author":"Sahastrabuddhe","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2019103013473843200_CIT0017","unstructured":"World Health Organization\u2014Immunizations, Vaccines, and Biologicals. Vaccine preventable diseases surveillance standards. Available at: http:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/standards\/en\/. Accessed 26 January 2019."},{"key":"2019103013473843200_CIT0018","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1586\/eri.11.47","article-title":"The utility of diagnostic tests for enteric fever in endemic locations","volume":"9","author":"Parry","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2019103013473843200_CIT0019","doi-asserted-by":"publisher","DOI":"10.1101\/327429.","article-title":"Diagnostic host gene signature to accurately distinguish enteric fever from other febrile diseases","author":"Blohmke","year":"2018","journal-title":"bioRxiv"},{"key":"2019103013473843200_CIT0020","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/cid\/ciy578","article-title":"Plasma immunoglobulin A responses against 2 Salmonella Typhi antigens identify patients with typhoid fever","volume":"68","author":"Andrews","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2019103013473843200_CIT0021","doi-asserted-by":"crossref","first-page":"e0006779","DOI":"10.1371\/journal.pntd.0006779","article-title":"A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid","volume":"12","author":"Britto","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"2019103013473843200_CIT0022","volume-title":"Antibiotic resistance threats in the United States, 2013","author":"Centers for Disease Control and Prevention"},{"key":"2019103013473843200_CIT0023","volume-title":"Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis","author":"World Health Organization.","year":"2017"},{"key":"2019103013473843200_CIT0024","doi-asserted-by":"crossref","first-page":"e00105","DOI":"10.1128\/mBio.00105-18","article-title":"Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins","volume":"9","author":"Klemm","year":"2018","journal-title":"mBio"},{"key":"2019103013473843200_CIT0025","author":"World Health Organization."},{"key":"2019103013473843200_CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.08.042","article-title":"The state of vaccine confidence 2016: global insights through a 67-country survey","author":"Larson","year":"2016","journal-title":"EBioMedicine"},{"key":"2019103013473843200_CIT0027","article-title":"Wellcome Global Monitor - First Wave Findings","author":"Gallup"},{"key":"2019103013473843200_CIT0028","unstructured":"World Health Organization. Measles in Europe: record number of both sick and immunized. Available at: http:\/\/www.euro.who.int\/en\/media-centre\/sections\/press-releases\/2019\/measles-in-europe-record-number-of-both-sick-and-immunized. Accessed 16 September 2019."},{"key":"2019103013473843200_CIT0029","doi-asserted-by":"crossref","first-page":"l739","DOI":"10.1136\/bmj.l739","article-title":"Philippines measles outbreak is deadliest yet as vaccine skepticism spurs disease comeback","volume":"364","author":"Dyer","year":"2019","journal-title":"BMJ"},{"key":"2019103013473843200_CIT0030"},{"key":"2019103013473843200_CIT0031","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF00145306","article-title":"Two outbreaks of typhoid fever related to the war in Bosnia and Herzegovina","volume":"12","author":"Bradari\u0107","year":"1996","journal-title":"Eur J Epidemiol"},{"key":"2019103013473843200_CIT0032","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10654-005-7454-6","article-title":"Outbreak of typhoid fever in vaccinated members of the French armed forces in the Ivory Coast","volume":"20","author":"Michel","year":"2005","journal-title":"Eur J Epidemiol"},{"key":"2019103013473843200_CIT0033","doi-asserted-by":"crossref","first-page":"148","DOI":"10.11604\/pamj.2018.29.148.12070","article-title":"Risk factors for transmission of Salmonella Typhi in Mahama refugee camp, Rwanda: a matched case-control study","volume":"29","author":"Nyamusore","year":"2018","journal-title":"Pan Afr Med J"},{"key":"2019103013473843200_CIT0034","unstructured":"Lee\n              A\n            \n          . South Sudanese refugee camp experiences spread of typhoid, 28 September 2016. Available at: http:\/\/www.coalitionagainsttyphoid.org\/south-sudanese-refugee-camp-experiences-spread-of-typhoid\/. Accessed 1 December 2018."},{"key":"2019103013473843200_CIT0035","unstructured":"World Health Organization. Vaccination in acute humanitarian emergencies. A Framework for decisionmaking. 2017. Available at: http:\/\/apps.who.int\/iris\/bitstream\/10665\/255575\/1\/WHO-IVB-17.03-eng.pdf. Accessed 16 September 2019."}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/Supplement_5\/S408\/30325990\/ciz483.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/Supplement_5\/S408\/30325990\/ciz483.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T19:32:39Z","timestamp":1572463959000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/69\/Supplement_5\/S408\/5587096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":35,"journal-issue":{"issue":"Supplement_5","published-online":{"date-parts":[[2019,10,15]]},"published-print":{"date-parts":[[2019,10,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz483","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11,1]]},"published":{"date-parts":[[2019,10,15]]}}}